Drug Screening - CD BioSciences

service-banner

Drug Screening

Drug Screening

Drug discovery is the process to identify potential therapeutic drugs for diseases of interest. It involves the identification of hits by compound screening, hit optimization and validation. Drug screening is to identify compounds that are promising for drug development before preclinical and clinical trials. The targets of screenings can be biomolecules (e.g., proteins) or interactions between biomolecules (e.g., protein-protein interactions) involved in pathological processes.

Signaling pathways regulate cellular activities such as immune response, metabolism, and cell proliferation. Malfunction of signaling pathways often leads to pathological or disease states, such as cancers, diabetes, and neurodegenerative diseases.

Possessing of a large scale of compound libraries including known drugs, and chemicals targeting certain signaling pathways, CD BioSciences has the ability of design, build and run fast and effective compound screenings, and deliver high-quality, validated hit compounds for your drug discovery project.

Drug screening

Our Services

With leading expertise and advanced equipment, we design and operate compound screening in various forms, such as:

  • High-throughput Screening (HTS)

    Unbiasedly screening compounds using our libraries of hundreds of thousands of compounds.

  • Medium-throughput Screening (MTS)

    Selectively screening compounds using our libraries against your target of interest.

  • Fragment Screening

    Efficiently identifying hits against targets of interest with our highly diverse fragment libraries.

  • High Content Screening (HCS)

    Utilizing high content imaging to analyze target-compound interaction while screening.

  • Mechanism of Action (MOA) Studies

    Characterizing the MOA of hits such as structure, target of binding.

Our Libraries

We also provide customized libraries covering signaling pathways such as PI3K/Akt/mTOR, MAPK, and NF-κB, and cellular processes such as autophagy, inflammation, and metabolism.

Cellular Processes Signaling Pathways Others
  • Anti-infection Compound Library
  • Autophagy Compound Library
  • Apoptosis Compound Library
  • Angiogenesis Library
  • Cell Cycle Library
  • DNA Damage/DNA Repair Library
  • Epigenetics Compound Library
  • Immunology/Inflammation Library
  • Histone Modification Library
  • Metabolism-related Library
  • GPCR Compound Library
  • Neuronal Signaling Compound Library
  • Tyrosine Kinase Inhibitor Library
  • Kinase Inhibitor Library
  • Ion Channel Compound Library
  • PI3K/Akt/mTOR Compound Library
  • JAK/STAT Compound Library
  • MAPK Inhibitor Library
  • NF-κB Signaling Library
  • TGF- β/Smad Compound Library
  • Ubiquitination Compound Library
  • Anti-cancer Compound Library
  • Anti-diabetic Compound Library
  • Anti-Virus Compound Library
  • Bioactive Compound Library
  • Clinical & FDA approved Drug Library
  • Human Endogenous Metabolite Compound Library
  • Inhibitor Library
  • Natural Product Library
  • Protease Inhibitor Library
  • Stem Cell Compound Library

Advantages of Our Screening Services

Drug screening

Extensive Experience

As a trusted service provider for decades, we are equipped with advanced platforms and highly experienced scientists dedicated to support you at every stage of your project.

Drug screening

Rich Sets of Libraries

We are in possession of a large collection of compound libraries, targeting different signaling pathways and disease-related processes.

Drug screening

A Wide Range of Assays

We offer assay services covering nearly every step of a project. Most of these assays are suitable for drug screening, such as Cell Health Assays, and especially Cell Signaling Pathway Reporter Screening.

Features

CD BioSciences offers cost-effect, high quality and hassle-free drug screening services to our clients worldwide. We guarantee to deliver our results on time. Please feel free to contact us.

For research use only. Not intended for any clinical use.